5,477 Shares in Zoetis Inc. (NYSE:ZTS) Bought by Union Bancaire Privee UBP SA

Union Bancaire Privee UBP SA bought a new stake in Zoetis Inc. (NYSE:ZTS) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund bought 5,477 shares of the company’s stock, valued at approximately $898,000.

A number of other large investors have also added to or reduced their stakes in ZTS. Blue Trust Inc. grew its position in shares of Zoetis by 85.1% in the 4th quarter. Blue Trust Inc. now owns 9,353 shares of the company’s stock worth $1,524,000 after buying an additional 4,301 shares during the last quarter. PFG Investments LLC boosted its stake in Zoetis by 3.7% in the fourth quarter. PFG Investments LLC now owns 3,265 shares of the company’s stock valued at $532,000 after acquiring an additional 115 shares in the last quarter. Regatta Capital Group LLC purchased a new position in Zoetis in the fourth quarter worth $1,743,000. Consolidated Investment Group LLC increased its position in shares of Zoetis by 22.9% during the fourth quarter. Consolidated Investment Group LLC now owns 17,200 shares of the company’s stock worth $2,803,000 after purchasing an additional 3,200 shares in the last quarter. Finally, Vista Investment Partners LLC lifted its holdings in shares of Zoetis by 1.7% during the 4th quarter. Vista Investment Partners LLC now owns 27,525 shares of the company’s stock valued at $4,485,000 after purchasing an additional 463 shares during the last quarter. 92.80% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several research analysts recently weighed in on ZTS shares. JPMorgan Chase & Co. boosted their target price on Zoetis from $225.00 to $230.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. UBS Group began coverage on Zoetis in a report on Monday, December 9th. They issued a “neutral” rating and a $196.00 price target for the company. Stifel Nicolaus cut their price objective on shares of Zoetis from $210.00 to $180.00 and set a “buy” rating on the stock in a report on Tuesday, January 7th. Leerink Partners initiated coverage on shares of Zoetis in a research note on Monday, December 2nd. They issued an “outperform” rating and a $215.00 target price for the company. Finally, Leerink Partnrs upgraded shares of Zoetis to a “strong-buy” rating in a research note on Monday, December 2nd. One investment analyst has rated the stock with a hold rating, nine have assigned a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, Zoetis has an average rating of “Buy” and a consensus target price of $211.89.

Zoetis Price Performance

NYSE:ZTS opened at $173.07 on Tuesday. The firm’s fifty day moving average is $170.10 and its two-hundred day moving average is $179.75. The firm has a market cap of $78.08 billion, a price-to-earnings ratio of 32.53, a PEG ratio of 2.57 and a beta of 0.89. The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.27 and a current ratio of 3.69. Zoetis Inc. has a one year low of $144.80 and a one year high of $200.53.

Zoetis (NYSE:ZTS) last issued its earnings results on Monday, November 4th. The company reported $1.58 EPS for the quarter, topping analysts’ consensus estimates of $1.46 by $0.12. The firm had revenue of $2.40 billion for the quarter, compared to the consensus estimate of $2.29 billion. Zoetis had a return on equity of 51.98% and a net margin of 26.55%. The company’s revenue was up 11.6% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.36 earnings per share. Research analysts expect that Zoetis Inc. will post 5.9 EPS for the current year.

Zoetis Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 4th. Stockholders of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 1.16%. This is a positive change from Zoetis’s previous quarterly dividend of $0.43. The ex-dividend date of this dividend is Tuesday, January 21st. Zoetis’s payout ratio is 37.59%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.